Proposed senescence amplification model for neovascular AMD and diabetic retinopathy
This abstract-only review proposes a hypothesis-generating, non-exclusive model in which senescence-related programs may amplify angiogenic, inflammatory, vascular and fibrotic dysfunction in neovascular age-related macular degeneration and proliferative diabetic retinopathy; it is not an established causal pathway. [1]
Automatic summary · not editorially reviewed
The key findings
Anti-VEGF therapy improved management, but recurrence, leakage, incomplete response and fibrosis or tractional complications suggest mechanisms beyond VEGF alone. [1]
Chronic stress in retina and choroid may induce senescence-associated or senescence-like remodeling in several cell types. [1]
The authors frame the model as hypothesis-generating and non-exclusive, not a fully established causal pathway. [1]
The source at a glance
- Study type / format
- Review abstract proposing a mechanistic model
- Population / context
- People with neovascular age-related macular degeneration or proliferative diabetic retinopathy, plus retinal and choroidal cell types discussed in the review
- Summary based on
- Study abstract
- Original publication
- August 7, 2026
Anti-VEGF limits in nAMD and PDR
The abstract states that neovascular age-related macular degeneration (nAMD) and proliferative diabetic retinopathy (PDR) remain major contributors to permanent visual impairment. Anti-vascular endothelial growth factor (anti-VEGF) therapy has substantially improved disease management, yet recurrent neovascularization, persistent leakage, incomplete treatment response, subretinal fibrosis in nAMD, and fibrovascular membrane formation or tractional complications in PDR suggest that progression involves mechanisms beyond VEGF signaling alone.
Supporting source [1]
Proposed feed-forward senescence amplification
Cellular senescence is described as a stress-induced condition with persistent cell-cycle arrest, altered stress responses and context-dependent senescence-associated secretory phenotype (SASP) activity. Chronic oxidative stress, hyperglycemia, hypoxia, metabolic dysfunction and inflammation in the retina and choroid may induce senescence-associated or senescence-like remodeling in retinal pigment epithelial cells, Müller glia, endothelial cells and pericytes. In the proposed model, such stress may initiate or reinforce senescence-related programs, while SASP factors, extracellular vesicles and immune microenvironment remodeling may further amplify dysfunction. The authors call this a hypothesis-generating, non-exclusive framework, not a fully established causal pathway.
Supporting source [1]
Scarce human evidence and senolytic questions
The abstract states that conclusive evidence of bona fide cellular senescence in human ocular tissues remains scarce and varies markedly across cell types and disease contexts. The review integrates direct experimental evidence, marker-based observations and inferred mechanistic insights, and compares disease-specific features of nAMD and PDR. It also discusses methodological challenges in defining retinal senescence and evaluates the translational potential and safety concerns of senolytics and SASP-modulating strategies as adjuncts to anti-VEGF therapy.
Supporting source [1]
How to interpret this
Abstract only; the full text was not reviewed. Conclusive evidence of bona fide senescence in human ocular tissues is described as scarce and variable. The model is proposed, not established, and senolytic or SASP-modulating strategies are discussed as adjuncts with safety concerns, not as validated treatments.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Wang Y, Luo T, Li C, Zhou L, Lin H, Yang MM. · europepmc.org · August 7, 2026